In the brains of humans and animals affected by prion disorders such as vCJD, BSE, scrapie, and chronic wasting disease, a cellular glycoprotein termed PrPC converts into an insoluble, pathogenic isoform designated PrPSc. Much evidence supports the notion that PrPSc is a crucial component of infectious prions. Although biophysical, biochemical, and in vivo infectivity studies have helped in defining the composition of infectious prions; the cellular mechanisms that mediate the generation of new infectious prions remain unknown. To address this question, the principal investigator has developed and characterized a unique system to amplify PrPSc 10-fold in brain membrane preparations in vitro without detergents or sonication. Consistent with the characteristics of PrPC conversion to PrPSc in vivo, this method this method of PrPSc amplification is species and strain specific, and depends on time, pH, and temperature. Using this system, the principal investigator has discovered that in addition to PrPC and PrPSc, specific host RNA molecules and a free thiolate anion are required for the in vitro amplification. The principal investigator has now been able to purify PrPC in an amplifiable state to carry out these conversion reactions. Based on these observations, the mechanisms underlying the conformational change of PrPC to PrPSc will be defined in three Specific Aims.
In Aim 1, novel cofactors required for PrPSc amplification in vitro will be identified.
In Aim 2, specific RNA molecules that catalyze PrPSc formation in vitro will be identified, and in Aim 3, the mechanism by which thiolate groups facilitate PrPSc amplification will be determined. These investigations will further our knowledge of the fundamental mechanism underlying prion propagation, and provide new directions in the investigation of neurodegenerative diseases. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS046478-01A1
Application #
6771405
Study Section
Special Emphasis Panel (ZRG1-CDIN (01))
Program Officer
Nunn, Michael
Project Start
2004-04-01
Project End
2008-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
1
Fiscal Year
2004
Total Cost
$354,391
Indirect Cost
Name
Dartmouth College
Department
Biochemistry
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Zhao, Yanding; Zurawel, Ashley A; Jenkins, Nicole P et al. (2018) Comparative Analysis of Mutant Huntingtin Binding Partners in Yeast Species. Sci Rep 8:9554
Noble, Geoffrey P; Dolph, Patrick J; Supattapone, Surachai (2016) Interallelic Transcriptional Enhancement as an in Vivo Measure of Transvection in Drosophila melanogaster. G3 (Bethesda) 6:3139-3148
Zurawel, Ashley A; Kabeche, Ruth; DiGregorio, Sonja E et al. (2016) CAG Expansions Are Genetically Stable and Form Nontoxic Aggregates in Cells Lacking Endogenous Polyglutamine Proteins. MBio 7:
Noble, Geoffrey P; Supattapone, Surachai (2015) Dissociation of recombinant prion autocatalysis from infectivity. Prion 9:405-11
Supattapone, Surachai (2015) Expanding the prion disease repertoire. Proc Natl Acad Sci U S A 112:11748-9
Noble, Geoffrey P; Wang, Daphne W; Walsh, Daniel J et al. (2015) A Structural and Functional Comparison Between Infectious and Non-Infectious Autocatalytic Recombinant PrP Conformers. PLoS Pathog 11:e1005017
Noble, Geoffrey P; Walsh, Daniel J; Miller, Michael B et al. (2015) Requirements for mutant and wild-type prion protein misfolding in vitro. Biochemistry 54:1180-7
Supattapone, Surachai (2014) Elucidating the role of cofactors in mammalian prion propagation. Prion 8:100-5
Supattapone, Surachai (2014) Synthesis of high titer infectious prions with cofactor molecules. J Biol Chem 289:19850-4
Zurawel, Ashley A; Walsh, Daniel J; Fortier, Sean M et al. (2014) Prion nucleation site unmasked by transient interaction with phospholipid cofactor. Biochemistry 53:68-76

Showing the most recent 10 out of 48 publications